UNUM Therapeutics is based in Cambridge, Massachusetts. It has raised $181M in total funding. Latest round: Series B.
UNUM Therapeutics is based in Cambridge, Massachusetts. UNUM Therapeutics has raised $181M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in June 2015. The round record for UNUM Therapeutics runs through 2015; nothing later has been disclosed. Investors on record include Atlas Venture, Brace Pharma, Cowen Private Investments, Jennison Associates, New Leaf Venture Partners, Novo A/S and 3 others. 9 distinct backers are named across the disclosed rounds.
Every UNUM Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Cambridge at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026